These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 13894938)

  • 1. Biological and chemical studies on mycobacteria. Relationship of colony morphology to mycoside content for Mycobacterium kansasil and Mycobacterium fortuitum.
    FREGNAN GB; SMITH DW; RANDALL HM
    J Bacteriol; 1961 Oct; 82(4):517-27. PubMed ID: 13894938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RELATIONSHIP OF MYCOSIDE CONTENT AND COLONY MORPHOLOGY FOR GROUP 2 AND GROUP 3 UNCLASSIFIED MYCOBACTERIA.
    NAVALKAR RG; WIEGESHAUS EH; SMITH DW
    J Bacteriol; 1964 Jul; 88(1):255-9. PubMed ID: 14198897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description of various colony forms of mycobacteria.
    FREGNAN GB; SMITH DW
    J Bacteriol; 1962 Apr; 83(4):819-27. PubMed ID: 13894939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutant of a scotochromogenic Mycobacterium detected by colony morphology and lipid studies.
    FREGNAN GB; SMITH DW; RANDALL HM
    J Bacteriol; 1962 Apr; 83(4):828-36. PubMed ID: 13894937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of mycoside F, a family of trehalose-containing glycolipids of Mycobacterium fortuitum.
    Gautier N; López Marín LM; Lanéelle MA; Daffé M
    FEMS Microbiol Lett; 1992 Nov; 77(1-3):81-7. PubMed ID: 1459422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotaxonomic analysis of glycolipids from Mycobacterium chelonae-M. fortuitum complex and bovine farcy strains.
    Hamid ME; Ridell M; Minnikin DE; Goodfellow M
    Zentralbl Bakteriol; 1998 Jul; 288(1):23-34. PubMed ID: 9728402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycopeptidolipids from Mycobacterium fortuitum: a variant in the structure of C-mycoside.
    López Marin LM; Lanéelle MA; Promé D; Daffé M; Lanéelle G; Promé JC
    Biochemistry; 1991 Oct; 30(43):10536-42. PubMed ID: 1931976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of a Mycobacterium kansasii phenolic glycolipid (mycoside A) immunoserum.
    Papa F; Riviere M; Fournié JJ; Puzo G; David H
    J Clin Microbiol; 1987 Dec; 25(12):2270-3. PubMed ID: 3429620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent assay of glycolipid antigens for identification of mycobacteria.
    Yanagihara DL; Barr VL; Knisley CV; Tsang AY; McClatchy JK; Brennan PJ
    J Clin Microbiol; 1985 Apr; 21(4):569-74. PubMed ID: 3886692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii, and other nontuberculous mycobacteria in an area of endemicity for AIDS.
    Shafer RW; Sierra MF
    Clin Infect Dis; 1992 Jul; 15(1):161-2. PubMed ID: 1617056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycoside G, a Specific Glycolipid in Mycobacterium marinum (Balnei).
    Navalkar RG; Wiegeshaus E; Kondo E; Kim HK; Smith DW
    J Bacteriol; 1965 Jul; 90(1):262-5. PubMed ID: 16562027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-pigmented rapidly growing mycobacteria smooth and rough colony phenotypes pathogenicity evaluated using in vitro and experimental models.
    García-Coca M; Aguilera-Correa JJ; Ibáñez-Apesteguía A; Rodríguez-Sevilla G; Romera-García D; Mahíllo-Fernández I; Reina G; Fernández-Alonso M; Leiva J; Muñoz-Egea MC; Del Pozo JL; Esteban J
    Pathog Dis; 2019 Jul; 77(5):. PubMed ID: 31583400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of porin genes from Mycobacterium fortuitum and their impact on growth.
    Sharbati S; Schramm K; Rempel S; Wang H; Andrich R; Tykiel V; Kunisch R; Lewin A
    BMC Microbiol; 2009 Feb; 9():31. PubMed ID: 19203364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity of Mycobacterium fortuitum and Mycobacterium smegmatis to goldfish, Carassius auratus.
    Talaat AM; Trucksis M; Kane AS; Reimschuessel R
    Vet Microbiol; 1999 Apr; 66(2):151-64. PubMed ID: 10227476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity and antigenicity of mycoside G and other glycolipids from Mycobacterium marinum.
    Cruaud P; Papa F; David HL; Daffé M
    Acta Leprol; 1989; 7 Suppl 1():94-7. PubMed ID: 2504015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic analysis of nontuberculous mycobacteria isolated from raw milk and human cases in Wisconsin.
    Ali ZI; Hanafy M; Hansen C; Saudi AM; Talaat AM
    J Dairy Sci; 2021 Jan; 104(1):211-220. PubMed ID: 33162087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of the glycolipid antigens of members of the third biovariant complex of Mycobacterium fortuitum.
    Lanëelle MA; Silve G; López Marín LM; Daffé M
    Eur J Biochem; 1996 May; 238(1):270-9. PubMed ID: 8665946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible intermediates in the biosynthesis of mycoside B by Mycobacterium microti.
    Thurman PF; Chai W; Rosankiewicz JR; Rogers HJ; Lawson AM; Draper P
    Eur J Biochem; 1993 Mar; 212(3):705-11. PubMed ID: 8462544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the toxic substances isolated from mycobacteria. I. Toxic glycolipids of Mycobacteria fortuitum and mycobacteria strain P16.
    AZUMA I; YAMAMURA Y
    J Chromatogr; 1962 Aug; 8():82-91. PubMed ID: 13863585
    [No Abstract]   [Full Text] [Related]  

  • 20. SDS-PAGE for identification of species belonging to the Mycobacterium fortuitum complex.
    Esteban J; Molleja A; Cabria F; Soledad Jiménez M
    Clin Microbiol Infect; 2003 Apr; 9(4):327-31. PubMed ID: 12667246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.